The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cardiopulmonary Auto-transfusion System-Global Market Insights and Sales Trends 2024
Synopsis
Cardiopulmonary auto-transfusion system is a device that provides autologous blood during surgical procedures.
The global Cardiopulmonary Auto-transfusion System market size is expected to reach US$ 600.5 million by 2029, growing at a CAGR of 1.9% from 2023 to 2029. The market is mainly driven by the significant applications of Cardiopulmonary Auto-transfusion System in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers and Others,, are propelling Cardiopulmonary Auto-transfusion System market. On-Pump Transfusion Device, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Off-Pump Transfusion Device segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cardiopulmonary Auto-transfusion System, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cardiopulmonary Auto-transfusion System market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cardiopulmonary Auto-transfusion System market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cardiopulmonary Auto-transfusion System sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cardiopulmonary Auto-transfusion System covered in this report include Haemonetics, Medtronic, LivaNova, Fresenius, Terumo Interventional Systems and Wandong Health Sources, etc.
The global Cardiopulmonary Auto-transfusion System market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Haemonetics
Medtronic
LivaNova
Fresenius
Terumo Interventional Systems
Wandong Health Sources
Global Cardiopulmonary Auto-transfusion System market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cardiopulmonary Auto-transfusion System market, Segment by Type:
On-Pump Transfusion Device
Off-Pump Transfusion Device
Global Cardiopulmonary Auto-transfusion System market, by Application
Hospitals
Ambulatory Surgical Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Cardiopulmonary Auto-transfusion System manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Cardiopulmonary Auto-transfusion System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Cardiopulmonary auto-transfusion system is a device that provides autologous blood during surgical procedures.
The global Cardiopulmonary Auto-transfusion System market size is expected to reach US$ 600.5 million by 2029, growing at a CAGR of 1.9% from 2023 to 2029. The market is mainly driven by the significant applications of Cardiopulmonary Auto-transfusion System in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers and Others,, are propelling Cardiopulmonary Auto-transfusion System market. On-Pump Transfusion Device, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Off-Pump Transfusion Device segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cardiopulmonary Auto-transfusion System, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cardiopulmonary Auto-transfusion System market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cardiopulmonary Auto-transfusion System market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cardiopulmonary Auto-transfusion System sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cardiopulmonary Auto-transfusion System covered in this report include Haemonetics, Medtronic, LivaNova, Fresenius, Terumo Interventional Systems and Wandong Health Sources, etc.
The global Cardiopulmonary Auto-transfusion System market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Haemonetics
Medtronic
LivaNova
Fresenius
Terumo Interventional Systems
Wandong Health Sources
Global Cardiopulmonary Auto-transfusion System market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cardiopulmonary Auto-transfusion System market, Segment by Type:
On-Pump Transfusion Device
Off-Pump Transfusion Device
Global Cardiopulmonary Auto-transfusion System market, by Application
Hospitals
Ambulatory Surgical Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Cardiopulmonary Auto-transfusion System manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Cardiopulmonary Auto-transfusion System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Cardiopulmonary Auto-transfusion System Market Overview
1.1 Cardiopulmonary Auto-transfusion System Product Overview
1.2 Cardiopulmonary Auto-transfusion System Market Segment by Type
1.2.1 On-Pump Transfusion Device
1.2.2 Off-Pump Transfusion Device
1.3 Global Cardiopulmonary Auto-transfusion System Market Size by Type
1.3.1 Global Cardiopulmonary Auto-transfusion System Market Size Overview by Type (2018-2029)
1.3.2 Global Cardiopulmonary Auto-transfusion System Historic Market Size Review by Type (2018-2023)
1.3.3 Global Cardiopulmonary Auto-transfusion System Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cardiopulmonary Auto-transfusion System Sales Breakdown by Type (2018-2023)
1.4.2 Europe Cardiopulmonary Auto-transfusion System Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Cardiopulmonary Auto-transfusion System Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Cardiopulmonary Auto-transfusion System Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Cardiopulmonary Auto-transfusion System Sales Breakdown by Type (2018-2023)
2 Global Cardiopulmonary Auto-transfusion System Market Competition by Company
2.1 Global Top Players by Cardiopulmonary Auto-transfusion System Sales (2018-2023)
2.2 Global Top Players by Cardiopulmonary Auto-transfusion System Revenue (2018-2023)
2.3 Global Top Players by Cardiopulmonary Auto-transfusion System Price (2018-2023)
2.4 Global Top Manufacturers Cardiopulmonary Auto-transfusion System Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cardiopulmonary Auto-transfusion System Market Competitive Situation and Trends
2.5.1 Cardiopulmonary Auto-transfusion System Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Cardiopulmonary Auto-transfusion System Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cardiopulmonary Auto-transfusion System as of 2022)
2.7 Date of Key Manufacturers Enter into Cardiopulmonary Auto-transfusion System Market
2.8 Key Manufacturers Cardiopulmonary Auto-transfusion System Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cardiopulmonary Auto-transfusion System Status and Outlook by Region
3.1 Global Cardiopulmonary Auto-transfusion System Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Cardiopulmonary Auto-transfusion System Historic Market Size by Region
3.2.1 Global Cardiopulmonary Auto-transfusion System Sales in Volume by Region (2018-2023)
3.2.2 Global Cardiopulmonary Auto-transfusion System Sales in Value by Region (2018-2023)
3.2.3 Global Cardiopulmonary Auto-transfusion System Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Cardiopulmonary Auto-transfusion System Forecasted Market Size by Region
3.3.1 Global Cardiopulmonary Auto-transfusion System Sales in Volume by Region (2024-2029)
3.3.2 Global Cardiopulmonary Auto-transfusion System Sales in Value by Region (2024-2029)
3.3.3 Global Cardiopulmonary Auto-transfusion System Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Cardiopulmonary Auto-transfusion System by Application
4.1 Cardiopulmonary Auto-transfusion System Market Segment by Application
4.1.1 Hospitals
4.1.2 Ambulatory Surgical Centers
4.1.3 Others
4.2 Global Cardiopulmonary Auto-transfusion System Market Size by Application
4.2.1 Global Cardiopulmonary Auto-transfusion System Market Size Overview by Application (2018-2029)
4.2.2 Global Cardiopulmonary Auto-transfusion System Historic Market Size Review by Application (2018-2023)
4.2.3 Global Cardiopulmonary Auto-transfusion System Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cardiopulmonary Auto-transfusion System Sales Breakdown by Application (2018-2023)
4.3.2 Europe Cardiopulmonary Auto-transfusion System Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Cardiopulmonary Auto-transfusion System Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Cardiopulmonary Auto-transfusion System Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Cardiopulmonary Auto-transfusion System Sales Breakdown by Application (2018-2023)
5 North America Cardiopulmonary Auto-transfusion System by Country
5.1 North America Cardiopulmonary Auto-transfusion System Historic Market Size by Country
5.1.1 North America Cardiopulmonary Auto-transfusion System Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Cardiopulmonary Auto-transfusion System Sales in Volume by Country (2018-2023)
5.1.3 North America Cardiopulmonary Auto-transfusion System Sales in Value by Country (2018-2023)
5.2 North America Cardiopulmonary Auto-transfusion System Forecasted Market Size by Country
5.2.1 North America Cardiopulmonary Auto-transfusion System Sales in Volume by Country (2024-2029)
5.2.2 North America Cardiopulmonary Auto-transfusion System Sales in Value by Country (2024-2029)
6 Europe Cardiopulmonary Auto-transfusion System by Country
6.1 Europe Cardiopulmonary Auto-transfusion System Historic Market Size by Country
6.1.1 Europe Cardiopulmonary Auto-transfusion System Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Cardiopulmonary Auto-transfusion System Sales in Volume by Country (2018-2023)
6.1.3 Europe Cardiopulmonary Auto-transfusion System Sales in Value by Country (2018-2023)
6.2 Europe Cardiopulmonary Auto-transfusion System Forecasted Market Size by Country
6.2.1 Europe Cardiopulmonary Auto-transfusion System Sales in Volume by Country (2024-2029)
6.2.2 Europe Cardiopulmonary Auto-transfusion System Sales in Value by Country (2024-2029)
7 Asia-Pacific Cardiopulmonary Auto-transfusion System by Region
7.1 Asia-Pacific Cardiopulmonary Auto-transfusion System Historic Market Size by Region
7.1.1 Asia-Pacific Cardiopulmonary Auto-transfusion System Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Cardiopulmonary Auto-transfusion System Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Cardiopulmonary Auto-transfusion System Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Cardiopulmonary Auto-transfusion System Forecasted Market Size by Region
7.2.1 Asia-Pacific Cardiopulmonary Auto-transfusion System Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Cardiopulmonary Auto-transfusion System Sales in Value by Region (2024-2029)
8 Latin America Cardiopulmonary Auto-transfusion System by Country
8.1 Latin America Cardiopulmonary Auto-transfusion System Historic Market Size by Country
8.1.1 Latin America Cardiopulmonary Auto-transfusion System Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Cardiopulmonary Auto-transfusion System Sales in Volume by Country (2018-2023)
8.1.3 Latin America Cardiopulmonary Auto-transfusion System Sales in Value by Country (2018-2023)
8.2 Latin America Cardiopulmonary Auto-transfusion System Forecasted Market Size by Country
8.2.1 Latin America Cardiopulmonary Auto-transfusion System Sales in Volume by Country (2024-2029)
8.2.2 Latin America Cardiopulmonary Auto-transfusion System Sales in Value by Country (2024-2029)
9 Middle East and Africa Cardiopulmonary Auto-transfusion System by Country
9.1 Middle East and Africa Cardiopulmonary Auto-transfusion System Historic Market Size by Country
9.1.1 Middle East and Africa Cardiopulmonary Auto-transfusion System Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Cardiopulmonary Auto-transfusion System Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Cardiopulmonary Auto-transfusion System Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Cardiopulmonary Auto-transfusion System Forecasted Market Size by Country
9.2.1 Middle East and Africa Cardiopulmonary Auto-transfusion System Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Cardiopulmonary Auto-transfusion System Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Haemonetics
10.1.1 Haemonetics Company Information
10.1.2 Haemonetics Introduction and Business Overview
10.1.3 Haemonetics Cardiopulmonary Auto-transfusion System Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Haemonetics Cardiopulmonary Auto-transfusion System Products Offered
10.1.5 Haemonetics Recent Development
10.2 Medtronic
10.2.1 Medtronic Company Information
10.2.2 Medtronic Introduction and Business Overview
10.2.3 Medtronic Cardiopulmonary Auto-transfusion System Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Medtronic Cardiopulmonary Auto-transfusion System Products Offered
10.2.5 Medtronic Recent Development
10.3 LivaNova
10.3.1 LivaNova Company Information
10.3.2 LivaNova Introduction and Business Overview
10.3.3 LivaNova Cardiopulmonary Auto-transfusion System Sales, Revenue and Gross Margin (2018-2023)
10.3.4 LivaNova Cardiopulmonary Auto-transfusion System Products Offered
10.3.5 LivaNova Recent Development
10.4 Fresenius
10.4.1 Fresenius Company Information
10.4.2 Fresenius Introduction and Business Overview
10.4.3 Fresenius Cardiopulmonary Auto-transfusion System Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Fresenius Cardiopulmonary Auto-transfusion System Products Offered
10.4.5 Fresenius Recent Development
10.5 Terumo Interventional Systems
10.5.1 Terumo Interventional Systems Company Information
10.5.2 Terumo Interventional Systems Introduction and Business Overview
10.5.3 Terumo Interventional Systems Cardiopulmonary Auto-transfusion System Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Terumo Interventional Systems Cardiopulmonary Auto-transfusion System Products Offered
10.5.5 Terumo Interventional Systems Recent Development
10.6 Wandong Health Sources
10.6.1 Wandong Health Sources Company Information
10.6.2 Wandong Health Sources Introduction and Business Overview
10.6.3 Wandong Health Sources Cardiopulmonary Auto-transfusion System Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Wandong Health Sources Cardiopulmonary Auto-transfusion System Products Offered
10.6.5 Wandong Health Sources Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cardiopulmonary Auto-transfusion System Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cardiopulmonary Auto-transfusion System Industrial Chain Analysis
11.4 Cardiopulmonary Auto-transfusion System Market Dynamics
11.4.1 Cardiopulmonary Auto-transfusion System Industry Trends
11.4.2 Cardiopulmonary Auto-transfusion System Market Drivers
11.4.3 Cardiopulmonary Auto-transfusion System Market Challenges
11.4.4 Cardiopulmonary Auto-transfusion System Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cardiopulmonary Auto-transfusion System Distributors
12.3 Cardiopulmonary Auto-transfusion System Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
